Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Alexia
ADR ID BADD_A06878
ADR Hierarchy
17      Nervous system disorders
17.02      Neurological disorders NEC
17.02.03      Cortical dysfunction NEC
17.02.03.014      Alexia
19      Psychiatric disorders
19.21      Cognitive and attention disorders and disturbances
19.21.01      Specific cognitive ability disturbances
19.21.01.008      Alexia
Description A cognitive disorder characterized by an impaired ability to comprehend written and printed words or phrases despite intact vision. This condition may be developmental or acquired. Developmental dyslexia is marked by reading achievement that falls substantially below that expected given the individual's chronological age, measured intelligence, and age-appropriate education. The disturbance in reading significantly interferes with academic achievement or with activities of daily living that require reading skills. (From DSM-IV) [MeSH]
MedDRA Code 10001663
MeSH ID D004410
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Alexia | Dyslexia | Dyslexias | Word Blindness | Blindness, Word | Blindnesses, Word | Word Blindnesses | Reading Disorder | Disorder, Reading | Disorders, Reading | Reading Disorders | Reading Disorder, Developmental | Developmental Reading Disorders | Disorder, Developmental Reading | Disorders, Developmental Reading | Reading Disorders, Developmental | Developmental Reading Disorder | Dyslexia, Developmental | Developmental Dyslexia | Developmental Dyslexias | Dyslexias, Developmental | Reading Disability, Developmental | Developmental Reading Disabilities | Developmental Reading Disability | Disabilities, Developmental Reading | Disability, Developmental Reading | Reading Disabilities, Developmental | Alexias
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00551Cyclosporine0.000111%
BADD_D02247Topiramate0.000201%
The 1th Page    1    Total 1 Pages